Source: Getty Images “Strengthening health care access and quality … will be paramount for improving clinical outcomes and slowing projected trends,” researchers wrote. The 18.5 million cancer deaths ...

Source: Getty Images Researchers identified a tumor cell-specific transcriptomic signature that appeared to be associated with treatment resistance and worse outcomes. The combination produced a ...

ALLO-316, a CD70-targeting CAR T-cell therapy, has demonstrated activity in patients with previously treated, advanced ccRCC.

Source: Getty Images Improving survival rates for patients with sarcomatoid differentiation can be attributed to advances in immunotherapy, according to researchers. The overall survival rate at 5 ...

Source: Shutterstock Researchers compared the nephrotoxicity of VEGF tyrosine kinase inhibitor (TKI) therapy alone, the combination of a VEGF TKI and an immune checkpoint inhibitor (ICI), and ICI-ICI ...

Source: Getty Images The combination of vidutolimod and nivolumab “stimulates a broad antitumor immune response,” according to researchers. Vidutolimod and nivolumab produced a major pathologic ...